Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-Operative Docetaxel-Cytoxan in HR+ Breast Cancer
NCT00832338Phase 2Terminated
- Sponsor
- Emory University
- Start
- Apr 2009
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in breast cancer, sponsored by Emory University. Started Apr 2009; status: terminated.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00832338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00832338.